ID   EF2K_RAT                Reviewed;         724 AA.
AC   P70531; O09089;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   24-JUL-2024, entry version 167.
DE   RecName: Full=Eukaryotic elongation factor 2 kinase;
DE            Short=eEF-2 kinase;
DE            Short=eEF-2K;
DE            EC=2.7.11.20 {ECO:0000269|PubMed:9144159};
DE   AltName: Full=Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase;
GN   Name=Eef2k {ECO:0000312|RGD:2538};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, CATALYTIC ACTIVITY, AND
RP   ACTIVITY REGULATION.
RC   TISSUE=Skeletal muscle;
RX   PubMed=8663182; DOI=10.1074/jbc.271.29.17547;
RA   Redpath N.T., Price N.T., Proud C.G.;
RT   "Cloning and expression of cDNA encoding protein synthesis elongation
RT   factor-2 kinase.";
RL   J. Biol. Chem. 271:17547-17554(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=New England Deaconess Hospital; TISSUE=Pheochromocytoma;
RX   PubMed=9144159; DOI=10.1073/pnas.94.10.4884;
RA   Ryazanov A.G., Ward M.D., Mendola C.E., Pavur K.S., Dorovkov M.V.,
RA   Wiedmann M., Erdjument-Bromage H., Tempst P., Parmer T.G., Prostko C.R.,
RA   Germino F.J., Hait W.N.;
RT   "Identification of a new class of protein kinases represented by eukaryotic
RT   elongation factor-2 kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:4884-4889(1997).
RN   [3]
RP   AUTOPHOSPHORYLATION.
RX   PubMed=8514778; DOI=10.1016/s0021-9258(19)38667-3;
RA   Mitsui K., Brady M., Palfrey H.C., Nairn A.C.;
RT   "Purification and characterization of calmodulin-dependent protein kinase
RT   III from rabbit reticulocytes and rat pancreas.";
RL   J. Biol. Chem. 268:13422-13433(1993).
RN   [4]
RP   PHOSPHORYLATION AT SER-499 BY PKA.
RX   PubMed=11171059; DOI=10.1042/0264-6021:3530621;
RA   Diggle T.A., Subkhankulova T., Lilley K.S., Shikotra N., Willis A.E.,
RA   Redpath N.T.;
RT   "Phosphorylation of elongation factor-2 kinase on serine 499 by cAMP-
RT   dependent protein kinase induces Ca2+/calmodulin-independent activity.";
RL   Biochem. J. 353:621-626(2001).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-73; THR-347; SER-365;
RP   SER-444; SER-469; SER-473 AND SER-476, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Threonine kinase that regulates protein synthesis by
CC       controlling the rate of peptide chain elongation. Upon activation by a
CC       variety of upstream kinases including AMPK or TRPM7, phosphorylates the
CC       elongation factor EEF2 at a single site, renders it unable to bind
CC       ribosomes and thus inactive. In turn, the rate of protein synthesis is
CC       reduced (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[translation elongation factor 2] + ATP = [translation
CC         elongation factor 2]-phosphate + ADP + H(+); Xref=Rhea:RHEA:21436,
CC         Rhea:RHEA-COMP:11268, Rhea:RHEA-COMP:11269, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43176, ChEBI:CHEBI:68546,
CC         ChEBI:CHEBI:456216; EC=2.7.11.20;
CC         Evidence={ECO:0000269|PubMed:9144159};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21437;
CC         Evidence={ECO:0000269|PubMed:9144159};
CC   -!- ACTIVITY REGULATION: Undergoes calcium/calmodulin-dependent
CC       intramolecular autophosphorylation, and this results in it becoming
CC       partially calcium/calmodulin-independent. {ECO:0000269|PubMed:9144159}.
CC   -!- SUBUNIT: Monomer or homodimer (Probable). Interacts with
CC       Calmodulin/CALM1; this interaction is strictly required for
CC       phosphorylation activity (By similarity).
CC       {ECO:0000250|UniProtKB:O00418, ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Widely expressed, with high levels in reticulocytes
CC       and skeletal muscle. {ECO:0000269|PubMed:8663182}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- PTM: Autophosphorylated at multiple residues, Thr-347 being the major
CC       site. Phosphorylated by AMP-activated protein kinase AMPK at Ser-397
CC       leading to EEF2K activation and protein synthesis inhibition.
CC       Phosphorylated by TRPM7 at Ser-77 resulting in improved protein
CC       stability, higher EE2F phosphorylated and subsequently reduced rate of
CC       protein synthesis. Phosphorylation by other kinases such as CDK1 and
CC       MAPK13 at Ser-358 or RPS6KA1 and RPS6KB1 at Ser-365 instead decrease
CC       EEF2K activity and promote protein synthesis (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Alpha-type
CC       protein kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X96426; CAA65286.1; -; mRNA.
DR   EMBL; U93849; AAB58272.1; -; mRNA.
DR   RefSeq; NP_037079.1; NM_012947.2.
DR   RefSeq; XP_006230218.1; XM_006230156.3.
DR   RefSeq; XP_006230219.1; XM_006230157.3.
DR   RefSeq; XP_006230220.1; XM_006230158.3.
DR   AlphaFoldDB; P70531; -.
DR   SMR; P70531; -.
DR   ELM; P70531; -.
DR   STRING; 10116.ENSRNOP00000022726; -.
DR   BindingDB; P70531; -.
DR   ChEMBL; CHEMBL3325307; -.
DR   GlyGen; P70531; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P70531; -.
DR   PhosphoSitePlus; P70531; -.
DR   PaxDb; 10116-ENSRNOP00000022726; -.
DR   Ensembl; ENSRNOT00000022726.6; ENSRNOP00000022726.3; ENSRNOG00000016448.8.
DR   Ensembl; ENSRNOT00065053902; ENSRNOP00065044340; ENSRNOG00065031250.
DR   GeneID; 25435; -.
DR   KEGG; rno:25435; -.
DR   UCSC; RGD:2538; rat.
DR   AGR; RGD:2538; -.
DR   CTD; 29904; -.
DR   RGD; 2538; Eef2k.
DR   eggNOG; ENOG502QVA3; Eukaryota.
DR   GeneTree; ENSGT00940000157839; -.
DR   HOGENOM; CLU_382143_0_0_1; -.
DR   InParanoid; P70531; -.
DR   OMA; QDAVNQN; -.
DR   OrthoDB; 317178at2759; -.
DR   PhylomeDB; P70531; -.
DR   TreeFam; TF316085; -.
DR   BRENDA; 2.7.11.20; 5301.
DR   Reactome; R-RNO-166208; mTORC1-mediated signalling.
DR   PRO; PR:P70531; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000016448; Expressed in skeletal muscle tissue and 20 other cell types or tissues.
DR   GO; GO:0043197; C:dendritic spine; IDA:SynGO-UCL.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005516; F:calmodulin binding; ISS:UniProtKB.
DR   GO; GO:0004686; F:elongation factor-2 kinase activity; IMP:RGD.
DR   GO; GO:0071454; P:cellular response to anoxia; IEP:RGD.
DR   GO; GO:1990416; P:cellular response to brain-derived neurotrophic factor stimulus; IEP:RGD.
DR   GO; GO:0071277; P:cellular response to calcium ion; IEP:RGD.
DR   GO; GO:0071320; P:cellular response to cAMP; IEP:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0031037; P:myosin II filament disassembly; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; IMP:RGD.
DR   GO; GO:0045807; P:positive regulation of endocytosis; IMP:RGD.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; IMP:RGD.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0031952; P:regulation of protein autophosphorylation; ISO:RGD.
DR   GO; GO:0140245; P:regulation of translation at postsynapse; IDA:SynGO.
DR   GO; GO:0002931; P:response to ischemia; IEP:RGD.
DR   GO; GO:1990637; P:response to prolactin; IEP:RGD.
DR   CDD; cd16967; Alpha_kinase_eEF2K; 1.
DR   Gene3D; 3.20.200.10; MHCK/EF2 kinase; 1.
DR   Gene3D; 1.25.40.10; Tetratricopeptide repeat domain; 1.
DR   InterPro; IPR004166; a-kinase_dom.
DR   InterPro; IPR051852; Alpha-type_PK.
DR   InterPro; IPR017400; eEF-2K.
DR   InterPro; IPR047588; eEF2K_a_kinase_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   PANTHER; PTHR45992:SF2; EUKARYOTIC ELONGATION FACTOR 2 KINASE; 1.
DR   PANTHER; PTHR45992; EUKARYOTIC ELONGATION FACTOR 2 KINASE-RELATED; 1.
DR   Pfam; PF02816; Alpha_kinase; 1.
DR   PIRSF; PIRSF038139; Elongation_factor_2_kinase; 1.
DR   SMART; SM00811; Alpha_kinase; 1.
DR   SUPFAM; SSF81901; HCP-like; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS51158; ALPHA_KINASE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Calcium; Calmodulin-binding; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:O00418"
FT   CHAIN           2..724
FT                   /note="Eukaryotic elongation factor 2 kinase"
FT                   /id="PRO_0000086938"
FT   DOMAIN          115..325
FT                   /note="Alpha-type protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00501"
FT   REGION          11..35
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          80..93
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000250|UniProtKB:O00418"
FT   REGION          353..476
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        378..404
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        419..473
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         295..301
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:O00418"
FT   MOD_RES         18
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O00418"
FT   MOD_RES         27
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O00418"
FT   MOD_RES         70
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O08796"
FT   MOD_RES         73
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         77
FT                   /note="Phosphoserine; by autocatalysis and TRPM7"
FT                   /evidence="ECO:0000250|UniProtKB:O00418"
FT   MOD_RES         242
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O00418"
FT   MOD_RES         347
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         352
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O00418"
FT   MOD_RES         358
FT                   /note="Phosphoserine; by MAPK13 and CDK1"
FT                   /evidence="ECO:0000250|UniProtKB:O00418"
FT   MOD_RES         365
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         391
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O08796"
FT   MOD_RES         397
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:O00418"
FT   MOD_RES         434
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O00418"
FT   MOD_RES         444
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         469
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         473
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         476
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         499
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:11171059"
SQ   SEQUENCE   724 AA;  81489 MW;  E4DDD832AE9F7165 CRC64;
     MADEDLIFRL EGVDGGGSSG AGRHGDSDTD SDDDEGYFIC PITDDHMSNQ NVNSKGQGYY
     NNLLKTECGS TGSPASSFHF KEAWKHAIEK AKHMPDPWAE FHLEDIATEH ATRHRYNAVT
     GEWLKDEVLI KMASQPFGRG AMRECFRTKK LSNFLHAQHW KGASNYVAKR YLEPVDRSVY
     FEDVQLQMEA KLWGEEYNRH KPPKQVDIMQ MCIIELKDRQ GQPLFHLEHY IEGKYIKYNS
     NSGFVRDDNI RLTPQAFSHF TFERSGHQLI VVDIQGVGDL YTDPQIHTEK GTDFGDGNLG
     VRGMALFFYS HACNRICQSM GLAPFDLSPR EQDAVNQSTK LLQSAKTILR GTEEKCGSPR
     IRTLSGSRPP LLLRLSENSG DENMSDVTFD SLPSSPSSAT PHSQKLDHLH WPVFGDLDNM
     GPRDHDRMDN HRDSENSGDS GYPSEKRSDL DDPEPREHGH SNGNRRPESD EDSLGSSGRV
     CVETWNLLNP SRLHLPRPSA VALEVQRLNA LDLGRKIGKS VLGKVHLAMV RYHEGGRFCE
     KDEEWDQESA IFHLEHAADL GELEAIVGLG LMYSQLPHHI LADVSLEETE ENKTKGFDYL
     LKAAEAGDRQ SMILVARAFD TGLNLSPDRC QDWSEALHWY NTALETTDCD EGGEYDGIQD
     EPQYALLARE AEMLLTGGFG LDKNPQRSGD LYTQAAEAAM EAMKGRLANQ YYEKAEEAWA
     QMEE
//
